div class=”ChapterContextInformation”>
10. Diabetes
10.1 Definition
Historically, gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy [1].
Defining diabetes in pregnancy
Fasting mg/dL | 1 h mg/dL | 2 h (75-g OGTT) mg/dL | HbA1C | Random | |
---|---|---|---|---|---|
DM/overt diabetes (any one criteria) | >126 | 200 | >6.5% | 200 mg/dL with symptoms of hyperglycemia | |
IADPSG (GDM) | |||||
92 mg/dL | 180 | 153 mg/dL | |||
DM | ≥126 | ≥200 | ≥6.5 | ||
Impaired fasting | 110–126 | 6.0–6.4 | |||
Impaired glucose tolerance | ≥140 | 6.0–6.4 |
10.2 Intrapartum Issues in Women with Diabetes
Good glycemic control remains important in the intrapartum period because maternal hyperglycemia during labor increases the risk of fetal acidemia and neonatal hypoglycemia. Intrapartum maternal normoglycemia will not reduce the risk of neonatal hypoglycemia in women with poor antepartum glycemic control, since fetal pancreatic hyperplasia and excessive in utero insulin secretion have been established in response to prolonged exposure to hyperglycemia.
10.2.1 Key Targets
During labor and delivery, the goal is to maintain normoglycemia, that is, blood glucose level between 70 and 126 mg/dL to prevent neonatal hypoglycemia [6, 7]. Intrapartum euglycemia is also important for preventing fetal hyperglycemia. If intrapartum hyperglycemia occurs on a background of chronically poor maternal metabolic control (high glycated hemoglobin [A1C]), this is an increased risk of fetal hypoxemia and acidosis.
10.2.2 Glucose Monitoring
Frequency of intrapartum blood sugar monitoring
Gestational diabetes on diet/medical therapy | At admission; 4–6 h | |
Type 1 diabetes Type 2 diabetes | Latent phase 2–4 h | Active phase 1–2 h 1 h if insulin infusion |
10.2.3 Intrapartum Insulin Administration
Intrapartum insulin administration protocols
Maternal plasma glucose mg/dL | Subcutaneous insulin (units) | Insulin infusion (units/h) | Rotating fluids protocol (only in women with GDM and not type 1 or type 2 diabetes) | |
---|---|---|---|---|
mg/dL | Fluid | |||
<100 | 5%DNS | |||
<120 | 0 | 0 | 100–140 | RL/NS |
121–140 | 1 | 1 | ||
141–160 | 2 | 2 | >140 | RL/NS with short or rapidacting insulin infusion to achieve a blood glucose of 100 mg/dL |
161–180 | 3 | 3 | ||
181–200 | 4 | 4 | ||
>200 | 4 plus IV regular insulin | 4 plus IV regular insulin | ||
Glucose monitoring | 2 hourly | 1 hourly |